2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetrone,4-ethyloctahydro-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[[3-(4-quinolinyl)propyl]amino]-10-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(3aS,4R,7R,9R,10R,11R,13R,15R,15aR)-
| Product Information | |
|---|---|
| Product Number: | AX-IWT1 |
| Product Name: | 2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetrone,4-ethyloctahydro-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[[3-(4-quinolinyl)propyl]amino]-10-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(3aS,4R,7R,9R,10R,11R,13R,15R,15aR)- |
| CAS: | 172678-62-5 |
| MW: | |
| Synonyms: | Erythromycin,3-de[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-11,12-dideoxy-6-O-methyl-3-oxo-12,11-[oxycarbonyl[[3-(4-quinolinyl)propyl]hydrazono]]-;HMR 3004; RU 004; RU 64004 |
| EINECS: | |
| Density: | |
| Melting Point: | |
| Boiling Point: | |
| Flash Point: | |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |